Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond
Authors
Keywords
-
Journal
Future Oncology
Volume 10, Issue 9, Pages 1679-1694
Publisher
Future Medicine Ltd
Online
2014-08-22
DOI
10.2217/fon.14.72
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort
- (2013) Chee L. Goh et al. BJU INTERNATIONAL
- Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
- (2013) D. W. Lin et al. CLINICAL CANCER RESEARCH
- Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression
- (2013) Zsofia Kote-Jarai et al. HUMAN MOLECULAR GENETICS
- Elevated Risk of Prostate Cancer Among Men With Lynch Syndrome
- (2013) Victoria M. Raymond et al. JOURNAL OF CLINICAL ONCOLOGY
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
- (2013) Rosalind A Eeles et al. NATURE GENETICS
- The genetic epidemiology of prostate cancer and its clinical implications
- (2013) Rosalind Eeles et al. Nature Reviews Urology
- Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E
- (2013) Robert J. MacInnis et al. PLoS One
- Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study
- (2013) Sheila Weinmann et al. PROSTATE
- G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis
- (2013) Hang Huang et al. TUMOR BIOLOGY
- A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice—the ProCaRis study: study protocol
- (2013) Pia Kirkegaard et al. BMJ Open
- The role of BRCA1 and BRCA2 in prostate cancer
- (2012) Elena Castro et al. ASIAN JOURNAL OF ANDROLOGY
- Germline BRCA1 mutations increase prostate cancer risk
- (2012) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- Beyond Prostate-specific Antigen — Future Biomarkers for the Early Detection and Management of Prostate Cancer
- (2012) E. Killick et al. CLINICAL ONCOLOGY
- A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
- (2012) A. Amin Al Olama et al. HUMAN MOLECULAR GENETICS
- Investigation of the Relationship Between Prostate Cancer andMSMBandNCOA4Genetic Variants and Protein Expression
- (2012) Liesel M. FitzGerald et al. HUMAN MUTATION
- Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion
- (2012) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
- (2012) Christoph Engel et al. JOURNAL OF CLINICAL ONCOLOGY
- Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics
- (2012) P. Hall JOURNAL OF INTERNAL MEDICINE
- Genetic variants associated with predisposition to prostate cancer and potential clinical implications
- (2012) C. L. Goh et al. JOURNAL OF INTERNAL MEDICINE
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese
- (2012) Shusuke Akamatsu et al. NATURE GENETICS
- Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4
- (2012) Jianfeng Xu et al. NATURE GENETICS
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis
- (2012) C. Grisanzio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel Germline mutation inHOXB13is associated with prostate cancer risk in Chinese men
- (2012) Xiaoling Lin et al. PROSTATE
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
- (2011) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration
- (2011) A. Cecile J. W. Janssens et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Genome-wide association study identifies new prostate cancer susceptibility loci
- (2011) Fredrick R. Schumacher et al. HUMAN MOLECULAR GENETICS
- Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study
- (2011) Gillian C Barnett et al. LANCET ONCOLOGY
- Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21
- (2011) Christopher A Haiman et al. NATURE GENETICS
- Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
- (2011) Zsofia Kote-Jarai et al. NATURE GENETICS
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
- (2011) S. A. Tomlins et al. Science Translational Medicine
- Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
- (2010) Anita V. Mitra et al. BJU INTERNATIONAL
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy
- (2010) Tibor Szarvas et al. INTERNATIONAL JOURNAL OF CANCER
- The Matrix Metalloproteinase-7 Polymorphism Rs10895304 Is Associated With Increased Recurrence Risk in Patients With Clinically Localized Prostate Cancer
- (2010) Jerry J. Jaboin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial
- (2010) E. David Crawford et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Prediction of Biochemical Recurrence After Radical Prostatectomy by Genetic Polymorphisms
- (2010) Juan Morote et al. JOURNAL OF UROLOGY
- Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
- (2010) Jonas Hugosson et al. LANCET ONCOLOGY
- Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
- (2010) Ryo Takata et al. NATURE GENETICS
- The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine
- (2010) Hayley C. Whitaker et al. PLoS One
- 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
- (2010) N. Ahmadiyeh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer
- (2009) E. M. Grindedal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Novel Prostate Cancer Susceptibility Locus at 19q13
- (2009) F.-C. Hsu et al. CANCER RESEARCH
- Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
- (2009) E Barrow et al. CLINICAL GENETICS
- A catalogue of reporting guidelines for health research
- (2009) I. Simera et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
- (2009) H. G. Welch et al. JNCI-Journal of the National Cancer Institute
- Bcl2 −938C/A Polymorphism Carries Increased Risk of Biochemical Recurrence After Radical Prostatectomy
- (2009) Hiroshi Hirata et al. JOURNAL OF UROLOGY
- The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens
- (2009) John D. Norris et al. MOLECULAR CELL
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
- (2009) Rosalind A Eeles et al. NATURE GENETICS
- Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
- (2009) Julius Gudmundsson et al. NATURE GENETICS
- Multiple loci on 8q24 associated with prostate cancer susceptibility
- (2009) Ali Amin Al Olama et al. NATURE GENETICS
- Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
- (2009) Thorunn Rafnar et al. NATURE GENETICS
- A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)
- (2009) Gilles Thomas et al. NATURE GENETICS
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Designing Genome-Wide Association Studies: Sample Size, Power, Imputation, and the Choice of Genotyping Chip
- (2009) Chris C. A. Spencer et al. PLoS Genetics
- Association of Megalin Genetic Polymorphisms with Prostate Cancer Risk and Prognosis
- (2008) S. K. Holt et al. CLINICAL CANCER RESEARCH
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- Missing data imputation and haplotype phase inference for genome-wide association studies
- (2008) Sharon R. Browning HUMAN GENETICS
- PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance
- (2008) Hiroyuki Nakanishi et al. JOURNAL OF UROLOGY
- PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome
- (2008) Ina L. Deras et al. JOURNAL OF UROLOGY
- Multiple loci identified in a genome-wide association study of prostate cancer
- (2008) Gilles Thomas et al. NATURE GENETICS
- Evidence for two independent prostate cancer risk–associated loci in the HNF1B gene at 17q12
- (2008) Jielin Sun et al. NATURE GENETICS
- Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
- (2008) Julius Gudmundsson et al. NATURE GENETICS
- Multiple newly identified loci associated with prostate cancer susceptibility
- (2008) Rosalind A Eeles et al. NATURE GENETICS
- Cumulative Association of Five Genetic Variants with Prostate Cancer
- (2008) S. Lilly Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started